Market Research Future published a research report on High Throughput Screening Market Research Report — Global Forecast till 2025– Market Overview, Segmentation, Progress, Regional analysis, key Trends, Major Players and Forecast to 2025. Global Wearable Sensors Market is likely to value of USD 13,460 million with a CAGR of 7.5% during the forecast period
Better integration of diverse plans in the global high throughput screening market and introduction of several strategic moves that encompasses mergers, acquisitions, tie-ups, and others are expected to inspire growth. Companies impacting the growth in the market are Danaher (US), Aurora Biomed Inc. (Canada), Tecan (Switzerland), PerkinElmer (US), Axxam (Italy), Hamilton (US), Corning (US), Merck Group (Germany), Beckman Coulter, Inc. (US), BioTek (US), Luminex Corporation (US), Agilent Technologies Inc. (US), and Roche (Switzerland).
High-throughput screening (HTS) can be defined as a method that includes scientific experimentation needed for various drug discovery and deciding typical moves in the the fields of biology and chemistry. The procedure includes data processing/control software, liquid handling devices, robotics, and sensitive detectors. This allows the system to get into the procedure of conducting tests for millions of chemical, genetic, or pharmacological processes. The process has evolved as necessary to find active compounds, antibodies, or genes that can cover various biomolecular pathway. This process assists in the designing of various market process.
The High Throughput Screening Market is getting traction from high technological advancements in HTS and hike in expenditure for research and development. The government funding for the procedure is also providing better scope for growth.
The global market for high throughput screening, by product & service, can be segmented into instruments, reagents & assay kits, consumables & accessories, and software and services. The reagents & assay kits segment can find growth with increasing demand from the diagnostic segment.
By technology, the global market report on high throughput screening can be segmented into cell-based assays, Bioinformatics, 3D cell culture, 2D cell culture, perfusion cell culture, 3D cell culture, Ultra-high-throughput Screening, lab-on-a-chip (LOC), and Label-free Technology. The 3D cell culture segment includes scaffold-based technologies and scaffold-free technologies. The scaffold-based segment comprises hydrogels, inert matrix, and micropatterned surfaces. The scaffold-free technologies segment consists ultra-low binding plates, hanging-drop plates, microplate, and other scaffold-free technologies.
By application, the global market for high throughput screening includes primary and secondary screening, toxicology assessment, target identification & validation, and others. The application segment is showing signs of fastest CAGR owing to its inclusion in the research and development sector.
By end user, the global market for high throughput screening can be segmented into contract research organizations, academic & government institutes, pharmaceutical & biotechnology companies, and others.
In October 2019, researchers at Sanford Burnham Prebys Medical Discovery Institute revealed that they have developed a machine-learning algorithm that would assist in the high throughput screening of epigenetic drugs.
About Market Research Future:
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.